Actively Recruiting
Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome
Led by Riphah International University · Updated on 2025-11-25
28
Participants Needed
1
Research Sites
14 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized clinical trial investigates the effects of Vojta therapy on functional mobility and gait parameters in children with down syndrome. The study involves 28 male and female children aged 2-10 years old, who will be randomly assigned to one of the two groups i.e. control and experimental group. Key performance outcomes -GMFM 88 and gait outcome assessment -will be assessed both before and after the intervention. The research aims to evaluate the effects of vojta therapy on functional mobility and gait parameters in children with down syndrome. This RCT study will examine the potential key parameters of gait I.e. its spacial parameters that are step length, stride length, stride width, In and out toe and BOS and functional mobility Data will be analyzed through SPSS version 27.00.
CONDITIONS
Official Title
Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 2 and 10 years old
- Confirmed diagnosis of Down syndrome by a pediatric neurologist
- Written informed consent obtained from parents or guardians
- Ability to stand and walk independently as assessed by GMFM dimensions D and E
- Functional hearing and vision with the ability to understand instructions needed for assessments
- No physical therapy or other interventions in the past three months
You will not qualify if you...
- Presence of other significant medical conditions such as severe heart problems
- History of orthopedic surgery or musculoskeletal issues affecting mobility
- Additional neurological disorders that could affect study results
- Serious cognitive or behavioral issues interfering with group participation
- Participation in other clinical trials during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hashim
Lahore, Punjab Province, Pakistan, 54000
Actively Recruiting
Research Team
I
IMRAN AMJAD, PhD
CONTACT
M
Muhammad Asif Javed, MS-PT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here